Cargando…
Interferon-Beta Injection in Multiple Sclerosis Patients Related to the Induction of Headache and Flu-Like Pain Symptoms: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Multiple sclerosis (MS) is a chronic neurodegenerative, inflammatory, and autoimmune disease characterised by the demyelination of the central nervous system. One of the main approaches for treating MS is the use of disease-modifying therapies (DMTs). Among the DMTs are interferons (IFNs), which are...
Autores principales: | Pereira, Leonardo Gomes, Rodrigues, Patrícia, Viero, Fernanda Tibolla, Frare, Julia Maria, Ramanzini, Luís Guilherme, Trevisan, Gabriela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881088/ https://www.ncbi.nlm.nih.gov/pubmed/34720084 http://dx.doi.org/10.2174/1570159X19666211101142115 |
Ejemplares similares
-
Prevalence of depression and anxiety in the different clinical forms of multiple sclerosis and associations with disability: A systematic review and meta-analysis
por: Peres, Diulle Spat, et al.
Publicado: (2022) -
Interferon-Beta-Induced Headache in Patients with Multiple Sclerosis: Frequency and Characterization
por: Elmazny, Alaa, et al.
Publicado: (2020) -
Unpredictable Sound Stress Model Causes Migraine-Like Behaviors in Mice With Sexual Dimorphism
por: Viero, Fernanda Tibolla, et al.
Publicado: (2022) -
Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority
por: Romano, Silvia, et al.
Publicado: (2019) -
Clinical Parameters to Predict Future Clinical Disease Activity After Treatment Change to Higher-Dose Subcutaneous Interferon Beta-1a From Other Platform Injectables in Patients With Relapsing-Remitting Multiple Sclerosis
por: Novotna, Martina, et al.
Publicado: (2020)